Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may amplify the drug's ability to regulate blood levels, potentially offering more significant outcomes for individuals with insulin resistance. Further study is underway to fully evaluate the